दवाओं की अंतःक्रिया
Interferon beta 1a + Tisagenlecleucel
गंभीरता: गंभीर
Interferon beta 1a and Tisagenlecleucel: major interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Tisagenlecleucel is a CAR-T cell therapy that causes prolonged cytopenias and immune compromise. Interferon beta may add to immune and blood count effects and could influence CAR-T cell activity. Clinical data on the combination are lacking.
इस इंटरैक्शन का सरल भाषा में अर्थ
Interferon beta 1a and Tisagenlecleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Interferon beta 1a belongs to Central Nervous System; Tisagenlecleucel belongs to Oncology.
ऐसा क्यों होता है
Additive immunosuppressive and myelosuppressive effects; the effect on CAR-T expansion is not established.
क्या करें
Avoid interferon beta around CAR-T therapy and choose an alternative where possible. If coadministered, monitor blood counts and infection signs closely.
फार्मासिस्ट से क्या पूछें
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Interferon beta 1a और Tisagenlecleucel की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Interferon beta 1a के अन्य इंटरैक्शन
Tisagenlecleucel के अन्य इंटरैक्शन
अक्सर पूछे जाने वाले प्रश्न
Can I take Interferon beta 1a with Tisagenlecleucel?
MediHelp rates the interaction as major. Interferon beta 1a and Tisagenlecleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Tisagenlecleucel is a CAR-T cell therapy that causes prolonged cytopenias and immune compromise. Interferon beta may add to immune and blood count effects and could influence CAR-T cell activity. Clinical data on the combination are lacking.
How serious is the interaction between Interferon beta 1a and Tisagenlecleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid interferon beta around CAR-T therapy and choose an alternative where possible. If coadministered, monitor blood counts and infection signs closely.
What other medicines interact with Interferon beta 1a?
MediHelp also lists interactions of Interferon beta 1a with, for example, Deferiprone, Etrasimod, Hydroxyurea. The full list is on the Interferon beta 1a page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
